Oncolytic viruses (OVs) infect, multiply, and finally remove tumor cells selectively, causing no
damage to normal cells in the process. Because of their specific features, such as, the ability …

Metastatic cancer cells generally cannot be eradicated using traditional surgical or
chemoradiotherapeutic strategies, and disease recurrence is extremely common following …

Cancer stands as one of the most leading causes of death worldwide, while one of the most
significant challenges in treating it is revealing novel alternatives to predict, diagnose, and …

Brain tumours have a poor prognosis and lack effective treatments. The blood–brain barrier
(BBB) represents a major hurdle to drug delivery to brain tumours. In some locations in the …

The field of drug delivery has grown tremendously in the past few decades by developing a
wide range of advanced drug delivery systems. An interesting category is cell-based drug …

Glioblastoma Multiforme (GBM) is one the most common intracranial tumors discovered by
Burns (1800) and Abernethy (1804) based on gross morphology of the autopsied material …

Cytopharmaceuticals, in which drugs/nanomedicines are loaded into/onto autologous
patient-or allogeneic donor-derived living cells ex vivo, have displayed great promise for …

Glioblastoma (GBM) is the most common primary malignant brain tumor diagnosed in adults,
carrying with it an extremely poor prognosis and limited options for effective treatment …

Cell therapy is an emerging and promising regenerative approach by cell replacement for
the treatment of diseases or injuries. Hydrogels, featuring high biocompatibility, tunable …

Cell-based therapies to the brain are promising for the treatment of multiple brain disorders
including neurodegeneration and cancers. In order to access the brain parenchyma, there …